Cote RJ - Search Results

1

Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.

Mitra AP, Datar RH, Cote RJ. Mitra AP, et al. Among authors: cote rj. J Clin Oncol. 2006 Dec 10;24(35):5552-64. doi: 10.1200/JCO.2006.08.2073. J Clin Oncol. 2006. PMID: 17158541 Review.

2

Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis.

Bochner BH, Cote RJ, Weidner N, Groshen S, Chen SC, Skinner DG, Nichols PW. Bochner BH, et al. Among authors: cote rj. J Natl Cancer Inst. 1995 Nov 1;87(21):1603-12. doi: 10.1093/jnci/87.21.1603. J Natl Cancer Inst. 1995. PMID: 7563203

3

p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer.

Esrig D, Spruck CH 3rd, Nichols PW, Chaiwun B, Steven K, Groshen S, Chen SC, Skinner DG, Jones PA, Cote RJ. Esrig D, et al. Among authors: cote rj. Am J Pathol. 1993 Nov;143(5):1389-97. Am J Pathol. 1993. PMID: 7901994 Free PMC article.

4

Accumulation of nuclear p53 and tumor progression in bladder cancer.

Esrig D, Elmajian D, Groshen S, Freeman JA, Stein JP, Chen SC, Nichols PW, Skinner DG, Jones PA, Cote RJ. Esrig D, et al. Among authors: cote rj. N Engl J Med. 1994 Nov 10;331(19):1259-64. doi: 10.1056/NEJM199411103311903. N Engl J Med. 1994. PMID: 7935683 Free article.

5

Two molecular pathways to transitional cell carcinoma of the bladder.

Spruck CH 3rd, Ohneseit PF, Gonzalez-Zulueta M, Esrig D, Miyao N, Tsai YC, Lerner SP, Schmütte C, Yang AS, Cote R, et al. Spruck CH 3rd, et al. Cancer Res. 1994 Feb 1;54(3):784-8. Cancer Res. 1994. PMID: 8306342

6

Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression.

Grossfeld GD, Ginsberg DA, Stein JP, Bochner BH, Esrig D, Groshen S, Dunn M, Nichols PW, Taylor CR, Skinner DG, Cote RJ. Grossfeld GD, et al. Among authors: cote rj. J Natl Cancer Inst. 1997 Feb 5;89(3):219-27. doi: 10.1093/jnci/89.3.219. J Natl Cancer Inst. 1997. PMID: 9017002

7

Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53.

Cote RJ, Dunn MD, Chatterjee SJ, Stein JP, Shi SR, Tran QC, Hu SX, Xu HJ, Groshen S, Taylor CR, Skinner DG, Benedict WF. Cote RJ, et al. Cancer Res. 1998 Mar 15;58(6):1090-4. Cancer Res. 1998. PMID: 9515785

8

Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer.

Stein JP, Ginsberg DA, Grossfeld GD, Chatterjee SJ, Esrig D, Dickinson MG, Groshen S, Taylor CR, Jones PA, Skinner DG, Cote RJ. Stein JP, et al. Among authors: cote rj. J Natl Cancer Inst. 1998 Jul 15;90(14):1072-9. doi: 10.1093/jnci/90.14.1072. J Natl Cancer Inst. 1998. PMID: 9672255

9

Prognostic markers in bladder cancer: a contemporary review of the literature.

Stein JP, Grossfeld GD, Ginsberg DA, Esrig D, Freeman JA, Figueroa AJ, Skinner DG, Cote RJ. Stein JP, et al. Among authors: cote rj. J Urol. 1998 Sep;160(3 Pt 1):645-59. doi: 10.1016/S0022-5347(01)62747-2. J Urol. 1998. PMID: 9720515 Review.

10

Relationship of tumor angiogenesis and nuclear p53 accumulation in invasive bladder cancer.

Bochner BH, Esrig D, Groshen S, Dickinson M, Weidner N, Nichols PW, Skinner DG, Cote RJ. Bochner BH, et al. Among authors: cote rj. Clin Cancer Res. 1997 Sep;3(9):1615-22. Clin Cancer Res. 1997. PMID: 9815851

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

224 results

Search Page